Imbed Biosciences, Inc. (Imbed) announced today that it has been awarded a $1.5 million two-year Small Business Innovation Research (SBIR) grant from the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the National Institutes of Health (NIH). The grant will support research to develop a bioresorbable wound dressing with silver and gallium metal ions that can kill bacteria hiding in biofilms in wounds.
“This antibiofilm dressing research program is built upon the clinical success of our next-generation FDA cleared Microlyte silver dressing that has been used in the treatment of thousands of chronic wounds patients in the U.S.,” said Ankit Agarwal, PhD, co-founder and CEO of the company and the Principal Investigator on the grant. Microlyte is an ultrathin polymeric film dressing made of bioresorbable synthetic polymers. It contains ionic and metallic silver that kill bacteria in contact with the dressing on a wound surface for up to three days. “Research in this NIH Phase II grant will document a synergy in the unique ability of gallium ions to penetrate biofilms and sensitize bacteria to the antimicrobial action of silver ions,” said Agarwal. Read the full story here.
;
